REHOVOT, Israel–(BUSINESS WIRE)–Aleph Farms, the first in vitro meat company to produce steaks directly from non-genetically modified animal cell culture, today announced that Kevin Benmoussa has been hired as Executive VP and Chief Financial Officer. He will be part of the management team, which otherwise consists of Didier Toubia (co-founder and CEO), Dr. Neta Lavon (CTO and VP R&D), Prof. Shulamit Levenberg (Co-Founder and Chief Scientific Adviser) and Yifat Gavriel (Chief Regulatory Affairs, QA and Product Safety). Based out of Aleph Farms’ first US headquarters in the historic Meatpacking District of New York City, Benmoussa will be responsible for the company’s global growth plans, leading its US operational expansion and providing financial,
“Kevin Benmoussa is a food and beverage industry veteran and brings invaluable experience in identifying and executing successful strategies for growth and profitability,” said Didier Toubia, CEO and co-founder of Aleph Farms. “Kevin joins Aleph Farms at an exciting time as we look to introduce a new category of animal products by gaining regulatory approvals, ramping up production and driving consumer acceptance.”
Kevin Benmoussa was formerly Chief Financial Officer at The Vita Coco Company, where he was responsible for expanding the company’s global finance functions before leading that company’s IPO in 2021. Prior to that, he held numerous leadership positions at Nestlé Waters North America, Inc. and PepsiCo Inc., where he drove growth and profitability through mergers and acquisitions, strategic alliances and business development.
“Aleph Farms is at an inflection point and has promising potential to significantly improve the way we approach animal product manufacturing by improving the sustainability, food safety and animal husbandry conditions of our food systems,” said Benmoussa. “I am extremely excited to be working with Didier Toubia and his team to drive this transformation from our new US office.”
Working closely with regulators around the world, Aleph Farms is preparing to launch its first product, a thinly sliced in vitro beef steak. In addition, the Company plans to manufacture various types of steaks as well as in vitro collagen through additional in-house capabilities. In all cases, Aleph Farms products are made from cell cultures derived from live cows that have not been immortalized or genetically modified. In this way slaughter is avoided and the production is part of an integrated solution for a sustainable and secure meat sector.
About Aleph Farms
Aleph Farms produces in vitro beef steaks from cell cultures obtained from live cows that have not been immortalized or genetically modified, thus avoiding slaughter and achieving a reduced environmental impact. The company was co-founded in 2017 by Didier Toubia of The Kitchen Hub by Strauss Group and Professor Shulamit Levenberg of the Technion – Israel Institute of Technology. Its vision is to provide unconditional nutrition for everyone, anytime, anywhere. For more information, join Aleph Farms on Instagram, Twitter, Facebook or LinkedIn or visit www.aleph-farms.com . Aleph Farms press kit is available here .
